Editorial for "amide Proton Transfer-Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer".

Jianqi Li

DOI: https://doi.org/10.1002/jmri.29468

2024-01-01

Abstract:Journal of Magnetic Resonance ImagingEarly View Editorial Editorial for "Amide Proton Transfer-Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer" Jianqi Li PhD, Corresponding Author Jianqi Li PhD [email protected] orcid.org/0000-0002-1860-2689 Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai, China E-mail: [email protected]Search for more papers by this author Jianqi Li PhD, Corresponding Author Jianqi Li PhD [email protected] orcid.org/0000-0002-1860-2689 Shanghai Key Laboratory of Magnetic Resonance, School of Physics and Electronic Science, East China Normal University, Shanghai, China E-mail: [email protected]Search for more papers by this author First published: 13 June 2024 https://doi.org/10.1002/jmri.29468 Evidence Level: 5 Technical Efficacy: Stage 2 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74(3): 229-263. 10.3322/caac.21834 PubMedWeb of Science®Google Scholar 2Comperat E, Amin MB, Cathomas R, et al. Current best practice for bladder cancer: A narrative review of diagnostics and treatments. Lancet 2022; 400(10364): 1712-1721. 10.1016/S0140-6736(22)01188-6 PubMedWeb of Science®Google Scholar 3Mertens LS, Claps F, Mayr R, et al. Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: A multi-center, multi-laboratory analysis in 1058 radical cystectomy patients. Urol Oncol 2022; 40(3): 110 e111-110 e119. 10.1016/j.urolonc.2021.10.010 Web of Science®Google Scholar 4Sanguedolce F, Zanelli M, Palicelli A, et al. HER2 expression in bladder cancer: A focused view on its diagnostic, prognostic, and predictive role. Int J Mol Sci 2023; 24(4): 3720. 10.3390/ijms24043720 CASPubMedWeb of Science®Google Scholar 5Zhou J, Heo HY, Knutsson L, van Zijl PCM, Jiang S. APT-weighted MRI: Techniques, current neuro applications, and challenging issues. J Magn Reson Imaging 2019; 50(2): 347-364. 10.1002/jmri.26645 PubMedWeb of Science®Google Scholar 6Wang HJ, Cai Q, Huang YP, et al. Amide proton transfer-weighted MRI in predicting histologic grade of bladder cancer. Radiology 2022; 305(1): 127-134. 10.1148/radiol.211804 PubMedWeb of Science®Google Scholar 7Kong L, Li H, Cai Q, et al. Amide proton transfer-weighted imaging in assessing the aggressive and proliferative potential of bladder cancer. J Magn Reson Imaging 2024. https://doi.org/10.1002/jmri.29464. 10.1002/jmri.29464 Web of Science®Google Scholar 8Heo HY, Jones CK, Hua J, et al. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T. J Magn Reson Imaging 2016; 44(1): 41-50. 10.1002/jmri.25108 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation